Schedule financial statements table text block |
|
|
For the Three Months Ended
February 28,
|
|
|
For the Six Months Ended
February 28,
|
|
|
|
As Reported |
|
|
Restated |
|
|
As Reported |
|
|
Restated |
|
Cost of Revenues |
|
$ |
3,942,314 |
|
|
$ |
4,302,972 |
|
|
$ |
7,211,646 |
|
|
$ |
8,033,525 |
|
Gross Profit |
|
|
1,466,429 |
|
|
|
1,105,771 |
|
|
|
3,878,773 |
|
|
|
3,056,894 |
|
Net Income (Loss) |
|
|
599,694 |
|
|
|
(960,352 |
) |
|
|
239,624 |
|
|
|
(582,253 |
) |
Earnings/(loss) per share (Basic and Diluted) |
|
$ |
0.02 |
|
|
$ |
(0.04 |
) |
|
$ |
0.01 |
|
|
$ |
(0.02 |
) |
|
Schedule of average dilutive common shares |
|
|
For
the three Month Ended
February
28, 2018
|
|
|
For
the
three
Month
Ended February 28, 2017
|
|
|
|
|
|
|
Options |
|
|
820,000 |
|
|
|
- |
|
Warrants |
|
|
2,570,413 |
|
|
|
2,160,725 |
|
Total
potentially dilutive shares |
|
|
3,390,413 |
|
|
|
2,160,725 |
|
|